Company Filing History:
1 out of 243 
1 out of 1,835 
1 out of 322 
Years Active: 2022
Title: François Brial: Innovator in Glucose Intolerance and Obesity Treatment
Introduction
François Brial is a notable inventor based in Villejuif, France. He has made significant contributions to the field of medical research, particularly in the prevention and treatment of glucose intolerance and obesity. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
François Brial holds 1 patent for his invention titled "Compounds for the prevention and treatment of glucose intolerance related conditions and obesity." This patent discloses a compound of formula (I), along with its pharmaceutically acceptable salts, or a composition comprising thereof, intended for use in the prevention or treatment of glucose intolerance related conditions, insulin deficit related conditions, nonalcoholic fatty liver disease, and obesity.
Career Highlights
Throughout his career, François Brial has worked with prestigious institutions such as Sorbonne Université and the Institut National de la Santé et de la Recherche Médicale. His research has focused on developing effective treatments for metabolic disorders, showcasing his commitment to improving public health.
Collaborations
François has collaborated with esteemed colleagues in his field, including Dominique Gauguier and Fumihiko Matsuda. These partnerships have enhanced his research and contributed to the advancement of medical science.
Conclusion
François Brial's innovative work in the treatment of glucose intolerance and obesity highlights his dedication to addressing significant health challenges. His contributions to medical research continue to impact the field positively.